DCF — REGIONAL MEDICAL CENTER OF SAN JOSE
Enterprise Value: $-1.0B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.0B
Enterprise Value
$-317.1M
PV of Cash Flows
$-712.7M
PV of Terminal Value
$-1.1B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $387.3M | $-68.9M | -18.0% | $-85.3M | $-77.5M |
| Year 2 | $398.9M | $-67.0M | -17.0% | $-83.8M | $-69.3M |
| Year 3 | $410.8M | $-64.9M | -16.0% | $-82.2M | $-61.8M |
| Year 4 | $423.2M | $-64.7M | -15.0% | $-82.6M | $-56.4M |
| Year 5 | $435.9M | $-65.5M | -15.0% | $-84.0M | $-52.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.0B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$376.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.1828508794363822
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5